Correlation Between Cue Biopharma and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Monopar Therapeutics, you can compare the effects of market volatilities on Cue Biopharma and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Monopar Therapeutics.
Diversification Opportunities for Cue Biopharma and Monopar Therapeutics
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cue and Monopar is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Cue Biopharma and Monopar Therapeutics
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Monopar Therapeutics. In addition to that, Cue Biopharma is 1.45 times more volatile than Monopar Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.41 per unit of volatility. If you would invest 1,457 in Monopar Therapeutics on September 1, 2024 and sell it today you would earn a total of 796.00 from holding Monopar Therapeutics or generate 54.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Monopar Therapeutics
Performance |
| Timeline |
| Cue Biopharma |
| Monopar Therapeutics |
Cue Biopharma and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Monopar Therapeutics
The main advantage of trading using opposite Cue Biopharma and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Cue Biopharma vs. Tff Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics | Cue Biopharma vs. Inhibrx | Cue Biopharma vs. Enliven Therapeutics |
| Monopar Therapeutics vs. Cue Biopharma | Monopar Therapeutics vs. Tff Pharmaceuticals | Monopar Therapeutics vs. Eliem Therapeutics | Monopar Therapeutics vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |